levodopa has been researched along with deoxyglucose in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (28.00) | 18.7374 |
1990's | 14 (56.00) | 18.2507 |
2000's | 2 (8.00) | 29.6817 |
2010's | 2 (8.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyce, S; Crossman, AR; Mitchell, IJ; Sambrook, MA | 1 |
James, CL; Trugman, JM; Wooten, GF | 1 |
Chase, TN; Engber, TM; Kuo, S; Susel, Z | 1 |
Boyce, S; Clarke, CA; Crossman, AR; Robertson, RG; Sambrook, MA | 1 |
Adam, MJ; Ammann, W; Bergstrom, M; Harrop, R; Laihinen, A; Martin, WR; Rogers, JG; Ruth, TJ; Sayre, CI; Stoessl, AJ | 1 |
Boyce, S; Clarke, CE; Crossman, AR; Robertson, RG; Sambrook, MA | 1 |
Firnau, G; Garnett, ES; Lang, AE; Nahmias, C; Talalla, A | 1 |
Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H | 1 |
Barash, V; Globus, M; Melamed, E; Weidenfeld, J | 1 |
Agid, Y; Baron, JC; Bustany, P; Collard, P; Comar, D; Rougemont, D | 1 |
Brown, LL; Warner, C; Wolfson, LI | 1 |
Lang, AE | 1 |
Antoni, G; Bergström, M; Bjurling, P; Jacobson, GB; Långström, B; Matsumura, K; Onoe, H; Takechi, H; Watanabe, Y; Westerberg, G | 1 |
Hawkins, RA | 1 |
Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ | 1 |
Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D | 1 |
Anderson, JJ; Boldry, RC; Chase, TN; Engber, TM; Kuo, S; Papa, SM | 1 |
Battistin, L; Dam, M; Fabbri, M; Pizzolato, G; Ricchieri, GL; Ruggero, S | 1 |
Trugman, JM | 1 |
Hirato, M; Horikoshi, S; Ishihara, J; Ohye, C; Shibazaki, T | 1 |
Akiguchi, I; Fukuyama, H; Hanakawa, T; Kato, M; Kimura, J; Shibasaki, H | 1 |
Alaynick, WA; During, MJ; Hnasko, TS; Palmiter, RD; Szczypka, MS | 1 |
Aubert, I; Bezard, E; Bioulac, BH; Bloch, B; Crossman, AR; Dovero, S; Gross, CE; Guigoni, C; Li, Q | 1 |
Bolner, A; De Riva, V; Nordera, GP; Pilleri, M | 1 |
Bastide, MF; Bézard, E; Boraud, T; de la Crompe, B; Doudnikoff, E; Fernagut, PO; Gross, CE; Mallet, N | 1 |
4 review(s) available for levodopa and deoxyglucose
Article | Year |
---|---|
MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Deoxyglucose; Haplorhini; Humans; Levodopa; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Spiperone | 1987 |
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water | 1986 |
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed | 1995 |
D1/D2 actions of dopaminergic drugs studied with [14C]-2-deoxyglucose autoradiography.
Topics: Animals; Autoradiography; Deoxyglucose; Levodopa; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1995 |
21 other study(ies) available for levodopa and deoxyglucose
Article | Year |
---|---|
A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Deoxyglucose; Female; Globus Pallidus; Levodopa; Macaca fascicularis; Male; Parkinson Disease; Thalamic Nuclei | 1992 |
D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study.
Topics: Animals; Autoradiography; Benzazepines; Biological Transport, Active; Brain; Carbon Radioisotopes; Deoxyglucose; Glucose; Levodopa; Male; Models, Neurological; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1991 |
Chronic levodopa treatment alters basal and dopamine agonist-stimulated cerebral glucose utilization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Basal Ganglia; Brain; Carbon Radioisotopes; Deoxyglucose; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Glucose; Levodopa; Male; Neural Pathways; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thalamus | 1990 |
The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Carbidopa; Corpus Striatum; Deoxyglucose; Flunitrazepam; gamma-Aminobutyric Acid; Globus Pallidus; Levodopa; Macaca fascicularis; Neurons; Organ Specificity; Parkinson Disease; Parkinson Disease, Secondary; Tritium | 1990 |
Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
Topics: Adult; Aged; Blood Glucose; Brain; Caudate Nucleus; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1987 |
Positron tomography in dystonia.
Topics: Brain; Circadian Rhythm; Deoxyglucose; Dystonia; Dystonia Musculorum Deformans; Fluorodeoxyglucose F18; Humans; Levodopa; Putamen; Tissue Distribution; Tomography, Emission-Computed | 1988 |
Effect of L-DOPA on glucose oxidation and incorporation into glycogen in discrete brain regions of the rat.
Topics: Animals; Brain; Cerebral Cortex; Corpus Striatum; Deoxyglucose; Glucose; Glycogen; Hippocampus; Hypothalamus; Levodopa; Male; Rats | 1985 |
Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.
Topics: Antiparkinson Agents; Autoradiography; Blood Glucose; Brain; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Humans; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1984 |
L-DOPA produces regional changes in glucose utilization which form discrete anatomic patterns in motor nuclei and the hypothalamus of rats.
Topics: Animals; Brain; Carbidopa; Corpus Striatum; Deoxyglucose; Glucose; Hypothalamus; Levodopa; Male; Motor Activity; Rats; Rats, Inbred Strains; Substantia Nigra | 1982 |
In vitro positron emission tomography (PET): use of positron emission tracers in functional imaging in living brain slices.
Topics: Animals; Brain; Buffers; Carbon Radioisotopes; Culture Media; Deoxyglucose; Dopamine; Dopamine Antagonists; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Kinetics; Levodopa; Male; Neurotransmitter Agents; Organ Culture Techniques; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Tomography, Emission-Computed | 1995 |
Pancreatic tumors: imaging with PET.
Topics: Adenocarcinoma; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed | 1995 |
MRI and PET studies of manganese-intoxicated monkeys.
Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Autoradiography; Brain; Carbon Radioisotopes; Deoxyglucose; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Levodopa; Male; Motor Activity; Organ Specificity; Oxidopamine; Quinoxalines; Rats; Rats, Sprague-Dawley | 1994 |
Selective D1 or D2 receptor blockade. Effects on brain functional responses to L-dopa.
Topics: Animals; Benzazepines; Blood Glucose; Brain; Brain Mapping; Deoxyglucose; Dopamine; Dopamine D2 Receptor Antagonists; Energy Metabolism; Levodopa; Male; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sulpiride | 1993 |
Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
Topics: Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chorea; Deoxyglucose; Dyskinesia, Drug-Induced; Electrodes, Implanted; Energy Metabolism; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Levodopa; Motor Neurons; Neural Pathways; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Thalamic Nuclei; Tomography, Emission-Computed; Tremor | 1995 |
[A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
Topics: Adult; Age of Onset; Brain; Deoxyglucose; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Parkinson Disease; Tomography, Emission-Computed | 1996 |
A role for dopamine in feeding responses produced by orexigenic agents.
Topics: Adenoviridae; Analysis of Variance; Animals; Antimetabolites; Behavior, Animal; Blood Glucose; Deoxyglucose; Dopamine; Dopamine Agents; Dopamine beta-Hydroxylase; Drug Interactions; Eating; Feeding Behavior; Food Deprivation; Genetic Vectors; Hypoglycemic Agents; Insulin; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide YY; Sincalide; Time Factors; Transduction, Genetic; Tyrosine 3-Monooxygenase | 2004 |
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Topics: Animals; Basal Ganglia; Deoxyglucose; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Levodopa; Limbic System; Macaca fascicularis; Motor Cortex; Parkinsonian Disorders; Septal Nuclei; Somatosensory Cortex; Substantia Nigra; Subthalamic Nucleus | 2005 |
Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Antiparkinson Agents; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Deoxyglucose; Deoxyguanosine; DNA Damage; DNA Repair; Electrochemical Techniques; Female; Humans; Levodopa; Male; Middle Aged; Oxidative Stress; Parkinson Disease | 2011 |
Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.
Topics: Animals; Corpus Striatum; Daunorubicin; Deoxyglucose; Disease Models, Animal; Dyskinesia, Drug-Induced; Electrophysiology; Female; Genes, Immediate-Early; Habenula; Levodopa; Macaca fascicularis; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2016 |